Literature DB >> 19683045

Quality and safety of Chinese herbal medicines guided by a systems biology perspective.

Jiangshan Wang1, Rob van der Heijden, Shannon Spruit, Thomas Hankermeier, Kelvin Chan, Jan van der Greef, Guowang Xu, Mei Wang.   

Abstract

Chinese herbal medicines, often referred as Chinese materia medica (CMM), are comprised of a complex multicomponent nature. The activities are aimed at the system level via interactions with a multitude of targets in the human body. This review aims at the toxicity aspects of CMM and its preparations at the different steps of production; harvesting, processing and the final formulation. The historic perspective and today's issues of the safety of CMM are introduced briefly, followed by the descriptions of the toxic CMM in the current Chinese Pharmacopoeia (2005). Subsequently, several aspects of safety are illustrated using a typical example of a toxic CMM, Aconitum roots, and some recent findings of our own research are included to illustrate that proper processing and multi-herbs formulation can reduce the level of toxic components. This also explains that in CMM, some herbs, such as Aconitum, Ephedra species are never used as single herb for intervention and that aconite is only used when it is processed and in combination with specific matched other herbs. The formulation principle of multi-herbs intervention strategy is a systems approach for the treatment and prevention of disease. In this light, the role of systems toxicology in the safety and quality of Chinese herbal medicine is proposed as a promising method. Moreover the principles of practiced-based and evidence-based research are discussed from a symbiotic perspective.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683045     DOI: 10.1016/j.jep.2009.07.040

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  26 in total

Review 1.  An overview on adverse drug reactions to traditional Chinese medicines.

Authors:  Kelvin Chan; Hongwei Zhang; Zhi-Xiu Lin
Journal:  Br J Clin Pharmacol       Date:  2015-05-19       Impact factor: 4.335

2.  Bridging the traditional Chinese medicine pattern classification and biomedical disease diagnosis with systems biology.

Authors:  Ai-ping Lu; Zhao-xiang Bian; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

Review 3.  Songling Xuemaikang Capsule () for primary hypertension: A systematic review of randomized controlled trials.

Authors:  Xiao-chen Yang; Xing-jiang Xiong; Guo-yan Yang; He-ran Wang; Jie Wang
Journal:  Chin J Integr Med       Date:  2014-03-02       Impact factor: 1.978

4.  A great honor and a huge challenge for China: You-you TU getting the Nobel Prize in Physiology or Medicine.

Authors:  Da Yuan; Xue Yang; Jun-Chao Guo
Journal:  J Zhejiang Univ Sci B       Date:  2016-05       Impact factor: 3.066

5.  Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label Study.

Authors:  Yichen Xu; Yanzhi Chen; Pingping Li; Xin Shelley Wang
Journal:  J Altern Complement Med       Date:  2015-04-28       Impact factor: 2.579

6.  Sulfur fumigation processing of traditional chinese medicinal herbs: beneficial or detrimental?

Authors:  Winnie Lai Ting Kan; Bin Ma; Ge Lin
Journal:  Front Pharmacol       Date:  2011-12-27       Impact factor: 5.810

7.  Drug Development Using Natural Toxins.

Authors:  Gihyun Lee
Journal:  Toxins (Basel)       Date:  2021-06-11       Impact factor: 4.546

8.  Zhen gan xi feng decoction, a traditional chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials.

Authors:  Xingjiang Xiong; Xiaochen Yang; Bo Feng; Wei Liu; Lian Duan; Ao Gao; Haixia Li; Jizheng Ma; Xinliang Du; Nan Li; Pengqian Wang; Kelei Su; Fuyong Chu; Guohao Zhang; Xiaoke Li; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-20       Impact factor: 2.629

9.  Outcome measures of chinese herbal medicine for hypertension: an overview of systematic reviews.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-24       Impact factor: 2.629

10.  Chinese herbal medicine qi ju di huang wan for the treatment of essential hypertension: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Xingjiang Xiong; Guoyan Yang; Yuqing Zhang; Yongmei Liu; Yun Zhang; Zhenpeng Zhang; Jun Li; Xiaochen Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.